Compounds > troleandomycin
Page last updated: 2024-09-05

troleandomycin and imipramine

troleandomycin has been researched along with imipramine in 5 studies

Compound Research Comparison

Studies
(troleandomycin)		Trials
(troleandomycin)		Recent Studies (post-2010)
(troleandomycin)		Studies
(imipramine)		Trials
(imipramine)		Recent Studies (post-2010) (imipramine)
569262310,3201,359801

Protein Interaction Comparison

ProteinTaxonomytroleandomycin (IC50)imipramine (IC50)
Solute carrier family 22 member 2Homo sapiens (human)0.6
Solute carrier family 22 member 1 Homo sapiens (human)7.95
Voltage-dependent L-type calcium channel subunit alpha-1CCavia porcellus (domestic guinea pig)8.3
Voltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)8.3
5-hydroxytryptamine receptor 2CRattus norvegicus (Norway rat)0.044
Muscarinic acetylcholine receptor M5Rattus norvegicus (Norway rat)0.3
Cytochrome P450 2D6Homo sapiens (human)0.0051
D(2) dopamine receptorHomo sapiens (human)0.41
5-hydroxytryptamine receptor 2ARattus norvegicus (Norway rat)0.044
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)0.16
Sphingomyelin phosphodiesteraseHomo sapiens (human)5
DRattus norvegicus (Norway rat)2.0992
D(3) dopamine receptorRattus norvegicus (Norway rat)0.81
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.044
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)3.3884
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)3.3884
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)3.3884
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)0.16
Sodium-dependent noradrenaline transporter Homo sapiens (human)0.074
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)3.3884
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.81
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.22
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)0.044
5-hydroxytryptamine receptor 1DRattus norvegicus (Norway rat)0.044
D(4) dopamine receptorRattus norvegicus (Norway rat)0.81
5-hydroxytryptamine receptor 1FRattus norvegicus (Norway rat)0.044
5-hydroxytryptamine receptor 2BRattus norvegicus (Norway rat)0.044
5-hydroxytryptamine receptor 6Rattus norvegicus (Norway rat)0.044
Histamine H1 receptorRattus norvegicus (Norway rat)0.0001
Sodium-dependent serotonin transporterHomo sapiens (human)0.0074
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)0.81
5-hydroxytryptamine receptor 7 Rattus norvegicus (Norway rat)0.044
5-hydroxytryptamine receptor 5ARattus norvegicus (Norway rat)0.044
5-hydroxytryptamine receptor 5BRattus norvegicus (Norway rat)0.044
Histamine H1 receptorHomo sapiens (human)0.027
Sodium channel protein type 1 subunit alphaHomo sapiens (human)3.6
Sodium channel protein type 4 subunit alphaHomo sapiens (human)3.6
5-hydroxytryptamine receptor 3ARattus norvegicus (Norway rat)0.044
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.16
Histamine H2 receptorCavia porcellus (domestic guinea pig)1.9
D(2) dopamine receptorRattus norvegicus (Norway rat)0.81
Sodium channel protein type 7 subunit alphaHomo sapiens (human)3.6
Voltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)8.3
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)3.3913
Voltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)8.3
Voltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)8.3
Sodium channel protein type 5 subunit alphaHomo sapiens (human)3.6
Sodium channel protein type 9 subunit alphaHomo sapiens (human)3.6
5-hydroxytryptamine receptor 4 Rattus norvegicus (Norway rat)0.044
Multidrug and toxin extrusion protein 1Homo sapiens (human)10
Sodium channel protein type 2 subunit alphaHomo sapiens (human)3.6
5-hydroxytryptamine receptor 3BRattus norvegicus (Norway rat)0.044
Sodium channel protein type 3 subunit alphaHomo sapiens (human)3.6
Solute carrier family 22 member 2Rattus norvegicus (Norway rat)9.9
Sodium channel protein type 11 subunit alphaHomo sapiens (human)3.6
Sodium channel protein type 8 subunit alphaHomo sapiens (human)3.6
TransporterRattus norvegicus (Norway rat)0.81
Sodium channel protein type 10 subunit alphaHomo sapiens (human)3.6

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ1
Kanakubo, Y; Kitada, M; Kiuchi, M; Ohmori, S; Rikihisa, T; Takeda, S1
Huang, SL; Wang, JS; Wang, W; Xie, HG; Zhou, HH1

Trials

1 trial(s) available for troleandomycin and imipramine

ArticleYear
Effect of troleandomycin on the pharmacokinetics of imipramine in Chinese: the role of CYP3A.
    British journal of clinical pharmacology, 1997, Volume: 44, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; China; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Humans; Imipramine; Male; Methylation; Microsomes, Liver; Oxidoreductases, N-Demethylating; Reference Values; Troleandomycin

1997

Other Studies

4 other study(ies) available for troleandomycin and imipramine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
    Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:1

    Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity

2013
Studies on cytochrome P450 responsible for oxidative metabolism of imipramine in human liver microsomes.
    Biological & pharmaceutical bulletin, 1993, Volume: 16, Issue:6

    Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Electrophoresis, Polyacrylamide Gel; Humans; Imipramine; Immunoblotting; In Vitro Techniques; Microsomes, Liver; Mixed Function Oxygenases; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Oxidoreductases, N-Demethylating; Propranolol; Quinidine; Quinine; Testosterone; Troleandomycin

1993